MACRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。MA遺伝子サイレンサーは、MA CRISPR/Cas9ノックアウトプラスミドとMADouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のMACRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
MA CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
MA1 CRISPR/Cas9 KOプラスミド (h) | sc-408458 | h | Gene Knockout | GFP | 0 | ||
MA1 HDRプラスミド (h) | sc-408458-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
MA1 Double Nickaseプラスミド (h) | sc-408458-NIC | h | Gene Knockout | Puromycin | 0 | ||
MA1 Double Nickaseプラスミド (h2) | sc-408458-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
MA1 CRISPR/Cas9 KOプラスミド (m) | sc-427724 | m | Gene Knockout | GFP | 0 | ||
MA1 HDRプラスミド (m) | sc-427724-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
MA1 Double Nickaseプラスミド (m) | sc-427724-NIC | m | Gene Knockout | Puromycin | 0 | ||
MA1 Double Nickaseプラスミド (m2) | sc-427724-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
MA2 CRISPR/Cas9 KOプラスミド (h) | sc-407564 | h | Gene Knockout | GFP | 0 | ||
MA2 HDRプラスミド (h) | sc-407564-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
MA2 Double Nickaseプラスミド (h) | sc-407564-NIC | h | Gene Knockout | Puromycin | 0 | ||
MA2 Double Nickaseプラスミド (h2) | sc-407564-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
MA2 CRISPR/Cas9 KOプラスミド (m) | sc-433668 | m | Gene Knockout | GFP | 0 | ||
MA2 HDRプラスミド (m) | sc-433668-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
MA2 Double Nickaseプラスミド (m) | sc-433668-NIC | m | Gene Knockout | Puromycin | 0 | ||
MA2 Double Nickaseプラスミド (m2) | sc-433668-NIC-2 | m | Gene Knockout | Puromycin | 0 |
MA CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
MA1 CRISPR Activationプラスミド (h) | sc-408458-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MA1 CRISPR Activationプラスミド (h2) | sc-408458-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MA1 Lentiviral Activation Particles (h) | sc-408458-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MA1 Lentiviral Activation Particles (h2) | sc-408458-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MA1 CRISPR Activationプラスミド (m) | sc-427724-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MA1 CRISPR Activationプラスミド (m2) | sc-427724-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MA1 Lentiviral Activation Particles (m) | sc-427724-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MA1 Lentiviral Activation Particles (m2) | sc-427724-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MA2 CRISPR Activationプラスミド (h) | sc-407564-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MA2 CRISPR Activationプラスミド (h2) | sc-407564-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MA2 Lentiviral Activation Particles (h) | sc-407564-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MA2 Lentiviral Activation Particles (h2) | sc-407564-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MA2 CRISPR Activationプラスミド (m) | sc-433668-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MA2 CRISPR Activationプラスミド (m2) | sc-433668-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MA2 Lentiviral Activation Particles (m) | sc-433668-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MA2 Lentiviral Activation Particles (m2) | sc-433668-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |